The French Pavilion Partners
CCI INTERNATIONAL GRAND EST is the operator for the support and international development of companies in the Grand Est region.
As a gateway to all the services offered by Team France Export, we provide tailor-made support to meet the needs of companies wishing to expand internationally.
Our team of export advisors, specialized by sector of activity, supports companies at each stage of their international development. CCI International Grand Est is leading the Grand Est business delegation at the BIO International Convention.
The Institut Pasteur is a globally recognized leader in infectious diseases, microbiology, and immunology
with research focusing on the biology of living systems and particularly molecules, cells, tissues, living organisms, and host-microbe interactions.
At Choose Paris Region, their core mission is to assist international companies in their expansion plans.
From initial decision-making to setting up, and every step in between, they provide market insights, connections, and resources to support companies who want to develop their business activities in France.
From market watch to implementation and re-invest, their goal is to help them take advantage of Paris Region’s exceptional talent and tech ecosystems to accelerate their growth.
Whether you need a specific service regarding one aspect of your expansion or full support throughout the project, they can help.
Their services are free, confidential, and customized. As an international company, you can access them at any stage of your project, regardless of the size of your company or its development stage.
With their support, unlock business opportunities in Paris Region and get the most out of the Region’s assets.
As a French biocluster, Lyonbiopole Auvergne-Rhône-Alpes is the gateway to healthcare innovation in Auvergne-Rhône-Alpes, France.
It aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges.
In 2024, Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients.
The cluster’s strategic missions are focused around:
- Innovate in a dynamic ecosystem
- Boost our members development
- Connect our Community
MATWIN is a French open innovation platform fully dedicated to the support of innovation in oncology (subsidiary of Unicancer, federation which gathers the 18 French Comprehensive Cancer Centres).
For 15 years, our platform has been offering various actions (expertise, accelerator programme, events, etc.) aiming to accelerate the development of innovative French & European projects dedicated to the fight against cancer.
Our platform is supported by ± 15 international partners (Amgen, AZ, Boehringer Ingelheim, BMS, Exact sciences, GSK, Insitro, MSD, Pfizer, Pierre Fabre, Roche, Sanofi, Takeda), willing to scout early promising innovations in the field. The disruptive & cutting-edge projects supported by MATWIN range from preclinical up to early clinical stage (Phase 1).
The French Tech Mission is a government administration whose objective is to support the structuring and growth of the French start-up ecosystem in France and globally.
As part of the Directorate-General for Enterprise within the Ministry of Economy, Finance and Industrial and Digital Sovereignty, the Mission coordinates and oversees the French Tech ecosystem with its network of 17 Capitals and 98 Communities, in France and abroad.
It also supports start-ups by making it easier for them to interact with the administration via a network of more than 60 French Tech contacts. The French Tech Mission supports the most mature start-ups through the French Tech Next40/120 program, as well as start-ups operating in sectors identified as strategic as part of the France 2030 plan with the French Tech 2030 program.
Through the French Tech Tremplin and French Tech Rise programs, the French Tech Mission enables people without an entrepreneurial background to create their own start-up anywhere in France, helps reducing gaps in funding, and promoting French Tech ecosystems throughout the country.
Last but not least, in oder to support the development of a competitive and efficient market, the French Tech Mission has created the program « Je choisis La French Tech » which aims at encouraging public administrations and corporates to buy solutions and innovations from French start-ups.
Inserm Transfert S.A. is the private subsidiary of the French National Institute of the Health and Medical Research (Inserm).
They are responsible for value creation of Inserm’s innovations in human health and promotes long-term technology transfers in line with international best practices.
Inserm Transfert S.A. was founded in 2000, and manages, under a Public Service Management Contract (Concession de Service Public), the entire innovation value chain and the transfer of knowledge from Inserm’s research laboratories to industry, from invention disclosure to industrial partnerships and startups incorporation.
Inserm Transfert also offers services relating to grant office, as well as supporting the technology transfer of clinical research and health data/databases and cohorts. Inserm Transfert is ISO 9001 v2015 certified for all its activities.
Largest life-sciences cluster in France, Medicen Paris Region brings together private and public players to develop the therapeutic solutions of tomorrow.
Medicen Paris Region federates more than 500 members, covering all the value chain – academics and clinical research, the largest EU hospital network, large companies and more than 400 start-ups and SMEs (Biotech, MedTech, Digital health).
Their main mission is to make the Paris Region the leading healthcare innovation ecosystem in Europe. In doing that Medicen gathers the whole regional ecosytem through their constant support to healthcare innovations to create therapeutic and economic value. As such, their activites can be summed up as follows:
– Support their members to consider new international markets.
– Shaping the ecosystem, creating the conditions for success and fostering growth. – Organisation of events about biomanufacturing, digital solution in hospitals and surgical innovation, among others.
– Helping companies looking for public and private funding.
AIS is the flagship measure of the “Healthcare Innovation” program, and its role is to manage the implementation of the health component of France 2030 in conjunction with the relevant ministries and operators.
Eurobiomed is the competitiveness cluster of the South of France, dedicated to Healthtech.
Established in 2009 by all stakeholders in the healthcare sector from the regions of Sud Provence Alpes Côte d’Azur and Occitanie, Eurobiomed brings together an ecosystem of over 400 industrial players, major corporations, SMEs, and startups, along with research laboratories and universities. They collaborate to develop and commercialize innovative products and services, aiming to generate growth and employment in promising markets.
Genopole shapes and vivifies a research hub for genomics and life sciences, energizes the growth of biotechnologies by creating, accompanying and welcoming innovative businesses, strengthens a life sciences academic center, and organizes lively scientific events at the biocluster.
Atlanpole Biotherapies is a non-profit organization truly involved in the medicine of tomorrow, with innovative areas of focus for the development of new therapies and the discovery of unexplored methodologies for human treatments.
The projects of network, both academic and industrial, show the excellence of our expertise in personalized medicine based on cutting-edge research and targeting strategies of extremely new therapies.
MabDesign is a unique membership organization that supports the development of the French industrial sector in the field of biotherapies with business and scientific expertise.
MabDesign provides strategic leverage and development opportunities for its 300, and growing, members. All and every action from MabDesign is based on their expertise in the biotherapy and bioproduction field.
BioLabs is an international, membership based network of shared lab and office facilities located in key biotech innovation clusters.
Located in 14 sites across the US and Europe, Biolabs is building strong biotech community for entrepreneurs and researchers.
Spartners, by Servier & BioLabs is a coworking space located in the innovative cluster of Paris-Saclay for life science startups – a unique place in which to test, develop and grow game changing ideas.
We offer state-of-the-art facilities, including fully equipped shared or private laboratory spaces with a dedicated technical team, as well as coworking spaces or private offices.
Thanks to the flexible terms and conditions of our site, we enable the most promising life science companies to work, collaborate and organize events in a setting perfectly suited to their needs. Our exclusive approach combines BioLabs’ expertise with Servier’s know-how, making it stand out in France.
FACC South California mission is to boost French and American businesses and individuals to create a more connected community, by providing them with opportunities to reach their full potential in the U.S.
Based in San Diego, they are a non-profit institution that empowers companies to reach their full potential. Through their expertise in business needs and regional regulation laws, as well as their expansive network of U.S. and French industry leaders and government officials, they help their members gain tremendous momentum to grow their business. Their mission is to enable and empower businesses by providing them with crucial resources, including but not limited to an extensive network, advice on best business practices, market studies, potential client prospection and outreach, recruitment, implantation, and more.
Based in Eastern France, the BioValley France cluster brings to the health sector its unique expertise and personalized support around 4 fields of expertise: Drugs and Innovative Therapies, E-health, Medical Technologies and Diagnosis.
For more than eighteen years, BioValley France has built a powerful community in order to deploy a strong network mixing academics and industrials in the health sector: more than 300 members and partners have decided to join the Cluster in order to share, exchange and develop tomorrow’s innovation in the best conditions. BioValley France offers services in: Business Competitiveness, Innovative Project, International Relations, Visibility and Influence.
France Biotech was founded in 1997 as an independent association, uniting the country’s leading innovative health companies and their expert partners.
As a leader in health innovation working in close cooperation with public authorities in France and across Europe, France Biotech is ideally positioned to address the challenges facing the HealthTech sector, notably corporate financing, taxation on innovation and regulatory and market access-related issues. Its committees and working groups strive to identify viable solutions to create the necessary conditions for a competitive and attractive industry. Its mission is to support HealthTech start-ups and SMEs in their quest for international expansion with the capability to rapidly design and develop new innovations and get them to the point of care. The association currently represents around 650 members.
Founded in 2009 by Caroline de Mareüil-Villette and Claire Verschelde, ICOSA is a European intellectual property firm dedicated to health.
As a human size company which gathers 80 professionals, ICOSA is agile and responsive. Its teams are composed of 30 European IP attorneys (EPO and EUIPO) and 24 French IP attorneys (INPI) holding doctorates and/or engineering or law degrees from top French or European schools and universities. Leveraging their scientific expertise and technical and legal skills, ICOSA’s experts master the specific challenges of intellectual property for each innovation or creation. Their attentive and highly available approach enables them to support their clients on a daily basis in decision-making and business growth.
ORCOM US specializes in setting up businesses and assisting French
subsidiaries with their accounting and tax needs in the US.
The firm mission: to play the role of interface between parent companies and their subsidiaries abroad as
an extension of the Financial and Administrative Department.
As the world’s largest law firm, Dentons offers its clients innovative legal solutions.
A Thomson Reuters top-ranked firm, winner of the BTI Client Service 30 Award, Dentons is also recognized by businesses and legal guides for its capacity to innovate, thanks in particular to Nextlaw Entreprise, Dentons’ subsidiary dedicated to new technologies. Dentons’ polycentric approach, its policy of inclusion and diversity, and the multicultural dimension of its talent challenge the status quo to promote the interests of clients worldwide.
Shahin Gharakhanian Consulting LLC provides clinical and medical expertise for patient-focused drug and vaccine development,
approval and launch programs.
Shahin Gharakhanian MD is a Physician-Executive with expertise in Pharmaceutical Medicine, Leadership and Management.
MFrance BioLead is the national player representing the French biomanufacturing sector.
Created in December 2022 with the support of the French government, France BioLead brings together all the players of French biotherapies value chain, including the academic research, training providers, manufacturers (pharmaceutical and biotechnology companies, CDMOs, CROs, equipment manufacturers, suppliers of technological solutions and consumables), competitive clusters, associations, and professional unions.
Their ambition is to make France the European leader in the biomanufacturing of innovative medicines in line with the France 2030 strategy.
Their missions? Structuring, steering, leading and promoting the French biomanufacturing industry in close collaboration with the French government.
Ipsen is a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Their pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Their teams in more than 40 countries and their partnerships around the world enable them to bring medicines to patients in more than 100 countries.
Ipsen is listed in Paris (Euronext: IPN) and in the U.S. through a Sponsored Level I American Depositary Receipt program (ADR: IPSEY).